Zhu Yun-Feng, Tan Yi-Fei, Xu Xi, Zheng Jin-Li, Zhang Bo-Han, Tang Huai-Rong, Yang Jia-Yin
Department of Liver Surgery and Liver Transplatation Centre.
Department of Physical Examination Center, West China Hospital, Sichuan University, Sichuan, China.
Medicine (Baltimore). 2019 Dec;98(50):e18319. doi: 10.1097/MD.0000000000018319.
Gamma-glutamyl transpeptidase-to-platelet ratio (GPR) and fibrosis-4 (FIB-4) index have been reported to be useful predictors in predicting hepatocellular carcinoma (HCC) development in chronic hepatitis B (CHB) patients. However, their predictive performances on HCC development have not been validated in elderly patients. Thus, the aim of this study was to evaluate the predictive values of the GPR and FIB-4 index on HCC in elderly CHB patients with in China.Between January 2007 and December 2016, 1011 CHB patients older than 60 years were enrolled in the study, and their data were retrospectively analyzed. Receiver-operating characteristic (ROC) curve analysis was used to determine the optimal cutoff points of GPR and the FIB-4 index. Cumulative HCC incidence rates were calculated by the Kaplan-Meier method and compared by the log-rank test. Univariate and multivariate analyses were performed to detect risk factors for HCC development. The prediction performances of GPR and FIB-4 index were compared based on time-dependent ROC analyses.After a median follow-up of 6.8 (interquartile range 3.9-8.4) years, 39 (3.9%) patients developed HCC. The ROC analysis of GPR and the FIB-4 index at the 5-year time point revealed that the optimal cutoff point was 0.23 for GPR and 4.15 for the FIB-4 index. When stratified by low and high GPR values and FIB-4 indices, the patients' subgroups showed significantly different cumulative incidences of HCC. The multivariate analysis revealed that high GPR (hazard ratio [HR] 4.224; 95% confidence interval [CI] 1.891-9.434, P < .001) was an independent risk factor for HCC development, whereas a high FIB-4 index was not (HR 0.470; 95% CI 0.212-1.043; P = .063). In the time-dependent ROC analysis, GPR showed higher area under curve (AUC) values than the FIB-4 index did at all time points and reached statistical significance at the 5-, 7-, and 10-year time points (GPR vs FIB-4 index, AUC 0.725 vs 0.549 at 5 years, P = .005; GPR vs FIB-4 index, AUC 0.733 vs 0.578 at 7 years, P = .001; GPR vs FIB-4 index, AUC 0.837 vs 0.475 at 10 years, P < .001).In conclusion, our study suggests GPR is superior to the FIB-4 index in predicting HCC development in elderly CHB patients in China.
据报道,γ-谷氨酰转肽酶与血小板比值(GPR)和纤维化-4(FIB-4)指数是预测慢性乙型肝炎(CHB)患者肝细胞癌(HCC)发生的有用指标。然而,它们对HCC发生的预测性能尚未在老年患者中得到验证。因此,本研究的目的是评估GPR和FIB-4指数对中国老年CHB患者HCC的预测价值。2007年1月至2016年12月,1011例60岁以上的CHB患者纳入本研究,并对其数据进行回顾性分析。采用受试者操作特征(ROC)曲线分析确定GPR和FIB-4指数的最佳截断点。采用Kaplan-Meier法计算HCC累积发病率,并通过对数秩检验进行比较。进行单因素和多因素分析以检测HCC发生的危险因素。基于时间依赖性ROC分析比较GPR和FIB-4指数的预测性能。中位随访6.8(四分位间距3.9 - 8.4)年后,39例(3.9%)患者发生HCC。GPR和FIB-4指数在5年时间点的ROC分析显示,GPR的最佳截断点为0.23,FIB-4指数为4.15。按低GPR值和高GPR值以及FIB-4指数分层时,患者亚组的HCC累积发病率有显著差异。多因素分析显示,高GPR(风险比[HR] 4.224;95%置信区间[CI] 1.891 - 9.434,P<0.001)是HCC发生的独立危险因素,而高FIB-4指数不是(HR 0.470;95% CI 0.212 - 1.043;P = 0.063)。在时间依赖性ROC分析中,GPR在所有时间点的曲线下面积(AUC)值均高于FIB-4指数,在5年、7年和10年时间点达到统计学意义(GPR与FIB-4指数比较,5年时AUC 0.725对0.549,P = 0.005;GPR与FIB-4指数比较,7年时AUC 0.733对0.578,P = 0.001;GPR与FIB-4指数比较,10年时AUC 0.837对0.475,P<0.001)。总之,我们的研究表明,在中国老年CHB患者中,GPR在预测HCC发生方面优于FIB-4指数。